Skip to content
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — Februar 2026

Genmab — Februar 2026

Planlagt Fastgjort Låst Flyttet Genmab
385 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • M Offline
    M Offline
    mortendrost1
    wrote on sidst redigeret af
    #188

    DNB Carnegie höjer riktkursen för Genmab till 2 300 danska kronor (2 235), upprepar köp
    i dag kl. 10:28

    1 Reply Last reply
    0
    • M Offline
      M Offline
      mortendrost1
      wrote on sidst redigeret af
      #189

      Lidt en omvendt dag, og ikke noget at sige til mange undrer sig over hvad der sker 🙂

      1 Reply Last reply
      0
      • StockBullS Offline
        StockBullS Offline
        StockBull
        wrote on sidst redigeret af
        #190

        Mange ser dette som dip-buy mulighed, især med buy-back aktiv. Rebound-potentiale: Hvis vi bouncer herfra (klassisk oversolgt + lav valuation), kan vi hurtigt se tilbage mod 1.900–1.950 (gårsdagens high/low fra rebound). Buy-back program (DKK 725 mio., startet i dag) hjælper med at støtte gulvet. Selv købt i 1831

        1 Reply Last reply
        0
        • M Offline
          M Offline
          mortendrost1
          wrote on sidst redigeret af
          #191

          Ja, jeg har også lige købt, efter den nu er banket i bund. Vil gerne lige over 1836 og gerne 1850 i dag. Så kan det være en klassisk rysten med træet.

          1 Reply Last reply
          0
          • StockBullS Offline
            StockBullS Offline
            StockBull
            wrote on sidst redigeret af
            #192

            Under 1.750 bliver det mere bearish, men det kræver typisk en ny trigger (f.eks. macro-salg i biotech eller negativ nyhed).

            1 Reply Last reply
            0
            • StockBullS Offline
              StockBullS Offline
              StockBull
              wrote on sidst redigeret af
              #193

              Jeg køber dip nær 1.835–1.750 - alternativt kan man vente på bekræftelse (f.eks. close over 1.850–1.870)?

              1 Reply Last reply
              0
              • M Offline
                M Offline
                mortendrost1
                wrote on sidst redigeret af
                #194

                Ja, enig i at 1850 vil stoppe det

                1 Reply Last reply
                0
                • M Offline
                  M Offline
                  mortendrost1
                  wrote on sidst redigeret af
                  #195

                  1850 vil stoppe faldet skulle der stå 🙂

                  1 Reply Last reply
                  0
                  • StockBullS Offline
                    StockBullS Offline
                    StockBull
                    wrote on sidst redigeret af
                    #196

                    Ja enig 🙂

                    1 Reply Last reply
                    0
                    • concilladoC Offline
                      concilladoC Offline
                      concillado
                      wrote on sidst redigeret af
                      #197

                      Det lader til at Danske Bank begynder at tilbagekøbe for GEN nu ;-).... kurs 1850

                      1 Reply Last reply
                      0
                      • M Offline
                        M Offline
                        mortendrost1
                        wrote on sidst redigeret af
                        #198

                        Såh luner det lidt igen. lad os se om den modreaktion vare ved 🙂

                        1 Reply Last reply
                        0
                        • concilladoC Offline
                          concilladoC Offline
                          concillado
                          wrote on sidst redigeret af
                          #199

                          Yup, tilbagekøb i et lidt surt marked er lidt som at tisse i bukserne 😄

                          1 Reply Last reply
                          0
                          • G Offline
                            G Offline
                            gentogen
                            wrote on sidst redigeret af
                            #200

                            A Study of GEN1106 in Participants With Solid Tumors.This is a first-in-human (FIH), open-label, multicenter, dose escalation and expansion trial in participants with urothelial and other cancers who have metastatic disease.https://clinicaltrials.gov/study/NCT07416123?term=genmab&aggFilters=status:not&rank=2

                            1 Reply Last reply
                            0
                            • E Offline
                              E Offline
                              E_L
                              wrote on sidst redigeret af
                              #201

                              William Blair analyst Matt Phipps has reiterated their bullish stance on GMAB stock, giving a Buy rating today. https://www.tipranks.com/news/ratings/genmab-near-term-guidance-miss-offset-by-strong-results-and-blockbuster-late-stage-pipeline-upside-ratings-news

                              1 Reply Last reply
                              0
                              • E Offline
                                E Offline
                                E_L
                                wrote on sidst redigeret af
                                #202

                                Goldman Sachs has lowered its price target for Genmab to 1,771 Danish kroner (previously 1,793), while reiterating its neutral rating

                                1 Reply Last reply
                                0
                                • P Offline
                                  P Offline
                                  ProinvestorNEWS
                                  wrote on sidst redigeret af
                                  #203

                                  Genmab/AL Sydbank: Investorerne fælder hård dom - fokus bør være på pipelinen https://proinvestor.com/investornyt/1413609/genmab-al-sydbank-investorerne-faelder-hard-dom-fokus-bor-vaere-pa-pipelinen

                                  1 Reply Last reply
                                  0
                                  • E Offline
                                    E Offline
                                    E_L
                                    wrote on sidst redigeret af
                                    #204

                                    H.C. Wainwright raised the firm's price target on Genmab to $40 from $39 and keeps a Buy rating

                                    1 Reply Last reply
                                    0
                                    • E Offline
                                      E Offline
                                      E_L
                                      wrote on sidst redigeret af
                                      #205

                                      if i would have to guess, i would say that is the ADC @gentogen , GEN1107
                                      was a Profound Bio ADC ?

                                      1 Reply Last reply
                                      0
                                      • G Offline
                                        G Offline
                                        gentogen
                                        wrote on sidst redigeret af
                                        #206

                                        sounds reasonable

                                        1 Reply Last reply
                                        0
                                        • E Offline
                                          E Offline
                                          E_L
                                          wrote on sidst redigeret af
                                          #207

                                          Genmab fik 79 mio. kr. i betaling fra Novo Nordisk i 2025
                                          Genmab fik samlet set 97 mio. dollar – svarende til over 613 mio. kr. – i milepælsbetalinger fra selskabets partnere i 2025. https://medwatch.dk/brancher/Medicinal___Biotek/article19028155.ece

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper